Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1416

1.

Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.

Malone JP, Gerberi MA, Vasireddy S, Hughes LF, Rao K, Shevlin B, Kuhn M, Collette D, Tennenhouse J, Robbins KT.

Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1119-25. doi: 10.1001/archoto.2009.152.

PMID:
19917925
2.

Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.

Tan A, Adelstein DJ, Rybicki LA, Saxton JP, Esclamado RM, Wood BG, Lorenz RR, Strome M, Carroll MA.

Arch Otolaryngol Head Neck Surg. 2007 May;133(5):435-40.

PMID:
17515501
3.

N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection?

Cho AH, Shah S, Ampil F, Bhartur S, Nathan CO.

Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1112-8. doi: 10.1001/archoto.2009.148.

PMID:
19917924
4.

Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?

Abgral R, Querellou S, Potard G, Le Roux PY, Le Duc-Pennec A, Marianovski R, Pradier O, Bizais Y, Kraeber-Bodéré F, Salaun PY.

J Nucl Med. 2009 Jan;50(1):24-9. doi: 10.2967/jnumed.108.055806. Epub 2008 Dec 17.

5.

Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.

Gourin CG, Boyce BJ, Williams HT, Herdman AV, Bilodeau PA, Coleman TA.

Laryngoscope. 2009 Nov;119(11):2150-5. doi: 10.1002/lary.20523.

PMID:
19544378
6.

18F-FDG versus 11C-choline PET/CT for the imaging of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy: the time period during which PET/CT can reliably detect non-recurrence.

Ito K, Yokoyama J, Kubota K, Morooka M, Shiibashi M, Matsuda H.

Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1318-27. doi: 10.1007/s00259-010-1400-x. Epub 2010 Mar 20.

PMID:
20306040
7.

Limitations of PET/CT in determining need for neck dissection after primary chemoradiation for advanced head and neck squamous cell carcinoma.

Lyford-Pike S, Ha PK, Jacene HA, Saunders JR, Tufano RP.

ORL J Otorhinolaryngol Relat Spec. 2009;71(5):251-6. doi: 10.1159/000237737. Epub 2009 Sep 16.

PMID:
19776658
8.

Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.

Gourin CG, Watts TL, Williams HT, Patel VS, Bilodeau PA, Coleman TA.

Laryngoscope. 2008 Apr;118(4):671-5. doi: 10.1097/MLG.0b013e3181625737.

PMID:
18197136
9.

Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer.

Zundel MT, Michel MA, Schultz CJ, Maheshwari M, Wong SJ, Campbell BH, Massey BL, Blumin J, Wilson JF, Wang D.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e825-32. doi: 10.1016/j.ijrobp.2010.11.072. Epub 2011 Feb 6.

PMID:
21300450
10.

Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.

Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, Gava M, Fanti S, Mariani G, Muzzio PC, Rubello D.

Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1583-93. Epub 2007 May 15.

PMID:
17503039
11.

Controversies in surgical management of the node-positive neck after chemoradiation.

Lango MN, Myers JN, Garden AS.

Semin Radiat Oncol. 2009 Jan;19(1):24-8. doi: 10.1016/j.semradonc.2008.09.005. Review.

PMID:
19028342
12.

PET monitoring of therapy response in head and neck squamous cell carcinoma.

Schöder H, Fury M, Lee N, Kraus D.

J Nucl Med. 2009 May;50 Suppl 1:74S-88S. doi: 10.2967/jnumed.108.057208. Epub 2009 Apr 20. Review.

13.
14.
15.

Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer.

Goguen LA, Posner MR, Tishler RB, Wirth LJ, Norris CM, Annino DJ, Sullivan CA, Li Y, Haddad RI.

Arch Otolaryngol Head Neck Surg. 2006 May;132(5):526-31.

PMID:
16702569
16.

Clinical usefulness of positron emission tomography-computed tomography in recurrent thyroid carcinoma.

Razfar A, Branstetter BF 4th, Christopoulos A, Lebeau SO, Hodak SP, Heron DE, Escott EJ, Ferris RL.

Arch Otolaryngol Head Neck Surg. 2010 Feb;136(2):120-5. doi: 10.1001/archoto.2009.215.

PMID:
20157055
17.

Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.

Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, Fan CY, Breau R, Suen J.

Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):861-7.

PMID:
15262764
18.

Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.

Guo H, Zhu H, Xi Y, Zhang B, Li L, Huang Y, Zhang J, Fu Z, Yang G, Yuan S, Yu J.

J Nucl Med. 2007 Aug;48(8):1251-8. Epub 2007 Jul 13.

19.

Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.

Frank DK, Hu KS, Culliney BE, Persky MS, Nussbaum M, Schantz SP, Malamud SC, Holliday RA, Khorsandi AS, Sessions RB, Harrison LB.

Laryngoscope. 2005 Jun;115(6):1015-20.

PMID:
15933512
20.

Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.

Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, Heilbrun M, Wiggins RH 3rd, Hunt JP, Bentz BG, Hitchcock YJ, Morton KA.

J Nucl Med. 2009 Aug;50(8):1205-13. doi: 10.2967/jnumed.109.062075. Epub 2009 Jul 17.

Supplemental Content

Support Center